Scholars Central

EditorialPublished 20 Feb 2017

EGFR - An Evolving Cancer Target

Authors: Dakir EL-H, Tanani EL-M, Dakir NM, Mendoza A, Morgan R

Cancer Biology and Therapeutic Oncology

Volume 1 · Issue 1 · Pages 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Epidermal Growth Factor Receptor (EGFR) plays an important role in initiating the signaling that directs the behaviour of epithelial cells and tumors of epithelial origin. EGFR is involved in cell signaling that controls cell proliferation, survival, and metastasis by regulating diverse cellular pathways, and is the most frequently mutated receptor in lung cancer (10% in the USA, 35% in Asia) [1,2], prompting an intensive effort to develop an effective drug to overcome EGFR-mutant-driven cancers. Resistance to EGFR tyrosine kinase inhibitors occurs in many cases of lung cancer. Here, we present a concise overview of the mechanisms involved in resistance and discusses a new approach to overcoming them.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Biology and Therapeutic Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Biology and Therapeutic Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Dakir EL-H”
  • BylineArticles whose byline prints “Tanani EL-M”
  • BylineArticles whose byline prints “Dakir NM”
  • BylineArticles whose byline prints “Mendoza A”
  • BylineArticles whose byline prints “Morgan R”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels